Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

NTSAD Virtual Family Conference | 2021 GM2 Sandhoff and Tay-Sachs Breakout

Ruben Giorgino, Head of Clinical Research and Development
Azafaros drug development program

Joel Ellis, PhD, Director of Toxicology
Recursion Pharmaceuticals drug development program

Suyash Prasad, MBBS, MSc, Chief Medical Officer & Head of R&D
Taysha gene therapies clinical trial

Erika De Boever, VP Clinical Development
Sio Gene Therapies clinical trial

Virtual Conference

View the NTSAD Annual Family Conference Research Exhibit Hall

Please contact Becky Benson, Conference and Family Services Coordinator here with any questions or concerns that are conference related.

2021 Conference Sponsors

Laura and Simeon Schindelman
Bonnie and Barry Davis in loving memory of Adam Davis 
The Evan Lee Ungerleider Fund
NTSAD New York Area Fund 
*sponsors as of 4/15/21